美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ritter Pharmaceuticals, Inc.

0.4480

0.0000

成交量：- -

成交額：- -

市值：2,067.65萬

市盈率：-1.03

高：0.4480

開：0.4480

低：0.4480

收：0.4480

52周最高：1.27

52周最低：0.1500

股本：4,615.30萬

流通股本：4,600.94萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.4357

每股收益(LYR):-1.0588

淨資產收益率：-144.14%

總資產收益率：-66.16%

市淨率：4.33

市盈率(LYR):-0.42

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Ritter Pharmaceuticals, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.ritterpharmaceuticals.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

里特製藥公司於2004年3月29日在內華達成立的一家名為“Ritter Natural Sciences, LLC”的有限責任公司，並於2008年9月16日轉換成特拉華州公司。里特製藥公司開發了通過調節人體腸道微生物來治療胃腸道疾病新的產品。該公司通過探索腸道菌群的代謝能力和轉換以益生元為基礎的治療劑以達到預期的影響從而推進人類腸道健康研究治療患者。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RTTR/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RTTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTTR\",,,,,undefined,":{"symbol":"RTTR","market":"US","secType":"STK","nameCN":"Ritter Pharmaceuticals, Inc.","latestPrice":0.448,"timestamp":1590177600000,"preClose":0.448,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":46009404,"shares":46152959,"eps":-0.435686,"marketStatus":"交易中","change":0,"latestTime":"03-10 14:38:41 EDT","open":0.448,"high":0.448,"low":0.448,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.435686,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"symbolChange":{"newSymbol":"QLGN","executeDate":"2020-05-26"},"adr":0,"adrRate":0,"listingDate":1435118400000,"exchange":"NASDAQ","adjPreClose":0.448,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RTTR\",,,,,undefined,":{"symbol":"RTTR","floatShares":46009404,"roa":"-66.16%","roe":"-144.14%","lyrEps":-1.058824,"shares":46152959,"dividePrice":0,"high":0.448,"amplitude":0,"preClose":0.448,"low":0.448,"week52Low":0.15,"pbRate":"4.33","week52High":1.27,"institutionHeld":0,"latestPrice":0.448,"eps":-0.435686,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.435686,"open":0.448},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RTTR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-26","symbol":"RTTR","type":"split","dateTimestamp":1590465600000,"forFactor":25,"toFactor":1,"ratio":25},{"market":"US","date":"2020-05-26","symbol":"RTTR","oldSymbol":"RTTR","newSymbol":"QLGN","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1590465600000},{"market":"US","date":"2020-05-01","symbol":"RTTR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1588305600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-03-31","symbol":"RTTR","fiscalQuarterEnding":"2019/12","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1585627200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2019-11-15","symbol":"RTTR","fiscalQuarterEnding":"2019/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1573794000000,"reportTimeType":"","actualEps":-0.83}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RTTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RTTR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ritterpharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.96},{"period":"1month","weight":-0.96},{"period":"3month","weight":-0.96},{"period":"6month","weight":-0.96},{"period":"1year","weight":-0.96},{"period":"ytd","weight":-0.96}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"里特製藥公司於2004年3月29日在內華達成立的一家名為“Ritter Natural Sciences, LLC”的有限責任公司，並於2008年9月16日轉換成特拉華州公司。里特製藥公司開發了通過調節人體腸道微生物來治療胃腸道疾病新的產品。該公司通過探索腸道菌群的代謝能力和轉換以益生元為基礎的治療劑以達到預期的影響從而推進人類腸道健康研究治療患者。","exchange":"NASDAQ","name":"Ritter Pharmaceuticals, Inc.","nameEN":"Ritter Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RTTR\",market:\"US\",,,undefined,":null}}